biologics

BIOPHARMA SHAKTI MISSION EXPLAINED

India launched a ₹13,000-crore initiative, including the BioPharma SHAKTI Mission and three chemical parks, to shift from generic drugs to high-value biologics and specialty chemicals. It targets the $300-billion biosimilars market, boosts R&D and regulation via CDSCO, reduces import dependence, and requires coordinated government action.